UK’s health and social care watchdog has decided against recommending Mounjaro, Eli Lilly’s weight loss drug for adults with diabetes. The National Institute for Health and Care Excellence (NICE) in the UK released draft guidance stating that they need more information about tirzepatide, the active ingredient in Mounjaro. “Our committee can see the promise in tirzepatide, but…
Sen. Sanders Asks Insulin Manufacturers to Testify Before Senate HELP Panel
Senate Health, Education, Labor, and Pensions (HELP) Committee Chairman Bernie Sanders has called the executives of top insulin manufacturers to testify before his panel. In an April 21 statement, Sanders (I-Vt.) announced a May 10 hearing of the HELP panel, entitled “The Need to Make Insulin Affordable for All Americans.” He also announced that the…
Major Drugmaker to Cut Insulin Prices for Americans, Cap Out-of-Pocket Costs at $35
Eli Lilly and Co. announced on Wednesday that prices for the company’s most commonly prescribed insulins will be reduced by up to 70 percent later this year, a move praised by President Joe Biden, who urged other drugmakers to follow. In a statement published on Mar. 1, the largest U.S. manufacturer of insulin said that…
FDA Pulls Authorization for Eli Lilly’s COVID-19 Drug Bebtelovimab
Eli Lilly and Co.’s COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, the Food and Drug Administration (FDA) said, citing it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron. Wednesday’s announcement takes away authorization from the last COVID-19 monoclonal antibody treatment, leaving Pfizer Inc.’s…
Alzheimer’s Drug Breakthrough Big Boost for Roche, Eli Lilly
LONDON—The results of a key Alzheimer’s drug trial on Wednesday have reignited decades-old hopes that targeting a particular protein helps arrest the progression of the fatal brain disease, giving a big boost to similar studies being run by Roche and Eli Lilly. Eisai Co Ltd and Biogen Inc said their experimental drug significantly slowed cognitive…
Eli Lilly Sued for Age Discrimination by US Agency EEOC
Eli Lilly and Co. was sued on Monday by the U.S. Equal Employment Opportunity Commission, which accused the drugmaker of illegally refusing to hire older workers for sales representative jobs because of their age. The complaint said Lilly’s violations began after Stephen Fry, its senior vice president for human resources and diversity, lamented during an…
Major Drug Company Announces Change Over Indiana’s Abortion Ban
Pharmaceutical giant Eli Lilly said it is looking to expand its Indiana-based headquarters outside the state after Indiana placed a ban on most abortions. “As a global company headquartered in Indianapolis for more than 145 years, we work hard to retain and attract thousands of people who are important drivers of our state’s economy. Given…
FDA Restricts Use of 2 Monoclonal Antibody Treatments
The U.S. Food and Drug Administration (FDA) announced Jan. 24 it is restricting the use of two monoclonal antibody treatments for COVID-19, saying data show such treatments are “highly unlikely” to be active against the Omicron variant, currently the dominant strain in the country. Monoclonal antibodies are laboratory-created proteins that mimic natural antibodies the body…
Judge Hears Opening Arguments on Biden Administration’s Alleged Purge of Industry From EPA Panels
December 23, 2021
admin
Department of JusticediscriminationEli LillyEnvironmentEPAExxonMobilIndustryJudge Timothy KellyJudiciaryScienceSupreme CourtU.S. District CourtUSUS News
0 Comment
Judge Timothy Kelly of the U.S. District Court for the District of Columbia heard opening arguments Dec. 22 on “Young vs. EPA,” which concerns allegations that the Environmental Protection Agency (EPA) illegally purged both its Clean Air Scientific Advisory Committee and its Science Advisory Board of representatives from the industries their decisions would regulate. One…
Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron
FRANKFURT, GERMANY—German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant of coronavirus, likely reducing treatment options if the new variant prevails. Two groups of Germany based scientists separately found that protection from GlaxoSmithKline and Vir’s antibody cocktail…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`